Total submissions: 8
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Gene |
RCV001531857 | SCV000570962 | likely benign | not provided | 2021-02-26 | criteria provided, single submitter | clinical testing | This variant is associated with the following publications: (PMID: 24895405) |
Fulgent Genetics, |
RCV000765316 | SCV000896572 | uncertain significance | Brittle cornea syndrome 1 | 2018-10-31 | criteria provided, single submitter | clinical testing | |
Ce |
RCV001531857 | SCV001747164 | likely benign | not provided | 2023-05-01 | criteria provided, single submitter | clinical testing | ZNF469: BP4 |
Labcorp Genetics |
RCV001531857 | SCV002370065 | likely benign | not provided | 2024-01-31 | criteria provided, single submitter | clinical testing | |
Genome Diagnostics Laboratory, |
RCV002279246 | SCV002565244 | likely benign | Ehlers-Danlos syndrome | 2022-03-01 | criteria provided, single submitter | clinical testing | |
Ambry Genetics | RCV002420232 | SCV002726030 | likely benign | Cardiovascular phenotype | 2019-02-14 | criteria provided, single submitter | clinical testing | This alteration is classified as likely benign based on a combination of the following: seen in unaffected individuals, population frequency, intact protein function, lack of segregation with disease, co-occurrence, RNA analysis, in silico models, amino acid conservation, lack of disease association in case-control studies, and/or the mechanism of disease or impacted region is inconsistent with a known cause of pathogenicity. |
Genome Diagnostics Laboratory, |
RCV001531857 | SCV001977717 | likely benign | not provided | no assertion criteria provided | clinical testing | ||
Clinical Genetics DNA and cytogenetics Diagnostics Lab, |
RCV001531857 | SCV001980566 | likely benign | not provided | no assertion criteria provided | clinical testing |